Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    FDA approves biosimilar filgrastim

    Author:
    HT Staff
    Publish date: July 22, 2018

    The US Food and Drug Administration (FDA) has approved the leukocyte growth factor Nivestym™ (filgrastim-aafi), a biosimilar to Neupogen (...

    • Read More

    News

    Tool may reveal optimal time for SCT in MF

    Author:
    HT Staff
    Publish date: July 21, 2018

    A new tool can help patients with myelofibrosis (MF) decide when to pursue stem cell transplant (SCT), according to the MPN Research Foundation....

    • Read More

    News

    Diabetics have higher risk of hematologic, other cancers

    Author:
    HT Staff
    Publish date: July 20, 2018

    A review of data from more than 19 million people indicates that diabetes significantly raises a person’s risk of developing cancer. When...

    • Read More

    News

    L-glutamine reduces complications of SCD

    Author:
    HT Staff
    Publish date: July 19, 2018

    Results of a phase 3 trial showed that L-glutamine can reduce complications of sickle cell disease (SCD). SCD patients who received...

    • Read More

    News

    How ALL invades the CNS

    Author:
    HT Staff
    Publish date: July 19, 2018

    Researchers believe they have solved the mystery of how acute lymphoblastic leukemia (ALL) infiltrates the central nervous system (CNS)....

    • Read More

    News

    Study suggests dasatinib could treat AML, JMML

    Author:
    HT Staff
    Publish date: July 18, 2018

    New research suggests dasatinib could treat certain patients with juvenile myelomonocytic leukemia (JMML) or acute myeloid leukemia (AML). The...

    • Read More

    News

    FDA grants UCB product orphan designation

    Author:
    HT Staff
    Publish date: July 18, 2018

    The US Food and Drug Administration (FDA) has granted orphan drug designation to NiCord for hematopoietic stem cell transplant. NiCord is created...

    • Read More

    News

    Product receives orphan designation for use in HSCT

    Author:
    HT Staff
    Publish date: July 18, 2018

    The US Food and Drug Administration (FDA) has granted orphan drug designation to dilanubicel (NLA101) for the reduction of morbidity and mortality...

    • Read More

    News

    Explaining enasidenib resistance in AML

    Author:
    HT Staff
    Publish date: July 17, 2018

    New research helps explain enasidenib resistance among patients with IDH2-mutant acute myeloid leukemia (AML). Researchers found that leukemic...

    • Read More

    News

    Investigators question utility of SFLCA

    Author:
    HT Staff
    Publish date: July 17, 2018

    Researchers are questioning the clinical usefulness of the serum free light chain assay (SFLCA) for patients with monoclonal gammopathies. The...

    • Read More

    News

    Vaccine protects mice from malaria

    Author:
    HT Staff
    Publish date: July 17, 2018

    An RNA replicon-based vaccine can fight malaria infection in mice, according to research published in Nature Communications. The vaccine targets...

    • Read More

    News

    Turbulence aids platelet production

    Author:
    HT Staff
    Publish date: July 16, 2018

    Turbulence promotes large-scale production of functional platelets from human induced pluripotent stem cells (hiPSCs), according to research...

    • Read More

    News

    Study links gut bacteria and TRALI

    Author:
    HT Staff
    Publish date: July 12, 2018

    A new study has revealed a previously unknown link between gastrointestinal flora and transfusion-related acute lung injury (TRALI). “We observed...

    • Read More

    News

    Protein could be target for MLL-rearranged AML

    Author:
    HT Staff
    Publish date: July 12, 2018

    Preclinical research has revealed a potential therapeutic target for MLL-rearranged acute myeloid leukemia (AML). The target—F-box protein S-...

    • Read More

    News

    FDA releases guidance docs on gene therapy

    Author:
    HT Staff
    Publish date: July 12, 2018

    The US Food and Drug Administration (FDA) has released several draft guidance documents on gene therapy. Three are disease-specific guidances—for...

    • Read More

    Pages

    • « first
    • …
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery